Seung Kew Yoon - Concepedia

Author

Seung Kew Yoon

Also Known As

Jong Young Choi, S K Yoon, S Yoon, S. K. Yoon, S. Yoon, S.K. Yoon, SEUNG KEW YOON, Seokchan Yoon, Seung K. Yoon, Seung Keun Yoon

530

Publications

14.4K

Citations

H-Index

196

Concepts

All Affiliations

Catholic University of Korea The Catholic University of Korea Seoul St. Mary's Hospital Yonsei University Pohang University of Science and Technology The Catholic University of Korea Incheon St. Mary's Hospital

About

Seung Kew Yoon is an author at Catholic University of Korea specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	98	5.5K
2	Health Sciences	19	24	1.3K
3	Public Health	7	7	596
4	Engineering	2	2	310
5	Natural Sciences	2	2	69

Seung Kew Yoon

231

Publications

12.1K

Citations

H-Index

Page 1

	Year	Citations
Entecavir Treatment for Up to 5 Years in Patients With Hepatitis B E Antigen–Positive Chronic Hepatitis B Ting‐Tsung Chang, Ching‐Lung Lai, Seung Kew Yoon, Hepatology	2010	581
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, The Lancet Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma	2023	415
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study Jorge A. Marrero, Masatoshi Kudo, Alan P. Venook, Journal of Hepatology Observational RegistryPediatric EpidemiologyClinical PopulationClinical EpidemiologyPediatrics	2016	376
The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin Sean Bong Lee, Karen Huang, Rachel Palmer, Cell Transcriptional RegulationGene RegulationTranscriptional ActivatorTumor SuppressorSystems Biology	1999	307
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer Jung Hyun Kwon, Si Hyun Bae, Ji Yoon Kim, BMC Cancer	2010	257
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma Myeong Jun Song, Ho Jong Chun, Do Seon Song, Journal of Hepatology Doxorubicin-eluting BeadsSurgical OncologyHepatologyMedicineTumor Targeting	2012	251
<scp>GIDEON</scp> (Global Investigation of therapeutic <scp>DE</scp> cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis Riccardo Lencioni, Masatoshi Kudo, Sheng‐Long Ye, International Journal of Clinical Practice	2013	222
A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Hepatology	2006	198
CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma Lian Shu Piao, Wonhee Hur, Taek‐Kyun Kim, Cancer Letters HepatologyHuman Hepatocellular CarcinomaMedicineLiver PhysiologyPathology	2011	197
Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B Eugene R. Schiff, Samuel S. Lee, You‐Chen Chao, Clinical Gastroenterology and Hepatology	2010	193

Page 1